Antiphospholipid Syndrome (APS) is an autoimmune disorder characterized by the production of antiphospholipid antibodies. These antibodies attack phospholipids, important components of cell membranes. APS leads to an increased risk of blood clotting, which can cause heart attack and stroke. It can also cause other p…
Antiphospholipid Syndrome (APS) is an autoimmune disorder characterized by the production of antiphospholipid antibodies. These antibodies attack phospholipids, important components of cell membranes. APS leads to an increased risk of blood clotting, which can cause heart attack and stroke. It can also cause other problems such as miscarriages, infertility, and cognitive impairment. Proper diagnosis and treatment of APS is critical to ensure a positive health outcome. Early treatment and lifestyle modifications can reduce the chances of complications occurring.
3 peer-reviewed articles, ranked by relevance. Each links to its DOI.
The 3 articles above have been cited 4 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
A sample of recent works citing this journal's research on Antiphospholipid Syndrome, linking to each citing work.